You are here

asundexian

New data reveal how Bayer's asundexian failed to prevent strokes, imperiling $5.5B blockbuster hopes

Fierce Biotech

Mon, 09/2/24 - 12:18 pm

clinical trials

atrial fibrillation

Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst

Fierce Pharma

Tue, 11/21/23 - 10:43 pm

Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast

Fierce Biotech

Mon, 11/20/23 - 11:41 am

clinical trials

Bayer doubles down on Factor XIa with new phase 3 trial

Pharmaphorum

Mon, 11/6/23 - 09:56 am

clinical trials

Factor Xa inhibition

atrial fibrillation

Bayer begins key tests for closely watched blood thinner

BioPharma Dive

Wed, 02/8/23 - 11:01 pm

clinical trials

Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race

Endpoints

Mon, 04/4/22 - 10:56 am

clinical trials

Bristol Myers Squibb